Varnimcabtagene autoleucel in relapsed / refractory B-cell malignancies: Manufacturing experience from India
Sign Up to like & getrecommendations! Published in 2025 at "Blood"
DOI: 10.1182/blood-2025-2409
Abstract: Introduction: Varnimcabtagene autoleucel (varnim-cel), a CD19 antigen-directed chimeric antigen receptor (CAR) T cell therapy with murine A3B1 binder, is currently approved in Spain (Hospital Exemption) for r/r B-ALL (> 25 years) and in India for… read more here.
Keywords: range median; cell; days range; varnim cel ... See more keywords